Page 1

Summary of Financial Statements for the Nine - month Period Ended December 31 , 2020 ( IFRS , Consolidated ) February 4 , 2021 Takeda Pharmaceutical Company Limited TSE Code : Representative : Contact : 4502 Stock exchange listings : URL : http://www.takeda.com Tokyo , Nagoya , Fukuoka , Sapporo Christophe Weber , President & CEO Telephone : + 81-3-3278-2306 Christopher O'Reilly Global Head of IR , Global Finance Scheduled date of securities report submission : February 12 , 2021 Scheduled date of dividend payment commencement : - Supplementary materials for the financial statements : Yes Presentation to explain for the financial statements : Yes 1 . ( Million JPY , rounded to the nearest million ) Consolidated Financial Results for the Nine - month Period Ended December 31 , 2020 ( April 1 to December 31 , 2020 ) ( 1 ) Consolidated Operating Results ( year to date ) ( Percentage figures represent changes over the same period of the previous year ) Net profit Revenue Operating profit Profit before tax for the period ( Million JPY ) ( % ) ( Million JPY ) ( % ) ( Million JPY ) ( % ) ( Million JPY ) ( % ) Nine - month Period Ended December 31 , 2020 2,427,538 ( 3.6 ) 358,729 120.7 235,357 320.2 179,027 319.0 Nine - month Period Ended December 31 , 2019 2,519,486 82.6 162,544 ( 42.9 ) 56,008 ( 73.1 ) 42,728 ( 74.0 ) Net profit attributable to owners of the Company Total comprehensive income for the period Basic earnings Diluted earnings per share per share ( Million JPY ) ( % ) ( Million JPY ) ( % ) ( JPY ) ( JPY ) Nine - month Period Ended December 31 , 2020 178,907 320.8 169,450 114.57 113.72 Nine - month Period Ended December 31 , 2019 42,517 ( 74.1 ) ( 44,081 ) 27.31 27.19 Core Operating Profit Core EPS ( Billion JPY ) ( % ) ( JPY ) Nine - month Period Ended December 31 , 2020 780.6 ( 1.5 ) 333 Nine - month Period Ended December 31 , 2019 792.2 129.9 360 ( 2 ) Consolidated Financial Position As of December 31 , 2020 As of March 31 , 2020 Total assets ( Million JPY ) 12,286,137 12,821,094 Total equity ( Million JPY ) 4,639,428 4,727,486 Equity attributable to owners of the Company ( Million JPY ) 4,635,353 4,723,483 Ratio of equity attributable to owners of the Company to total assets ( % ) 37.7 36.8 Equity attributable to owners of the Company per share ( JPY ) 2,965.00 3,032.22